Bryson Publications

  1. Bryson TD, Harding P. Prostaglandin E2 and myocarditis; friend or foe? Biochem Pharmacol. 2023 Sep 16;217:115813. doi: 10.1016/j.bcp.2023.115813. PMID: 37722627
  2. Maxwell DL, Bryson TD, Taube D, Xu J, Peterson E, Harding P. Deleterious effects of cardiomyocyte-specific prostaglandin E2 EP3 receptor overexpression on cardiac function after myocardial infarction. Life Sci. 2023 Jan 15;313:121277. doi: 10.1016/j.lfs.2022.121277. PMID: 36521546
  3. Zhang R, Bryson TD, Fogo GM, Liao J, Raghunayakula S, Mathieu J, Wider JM, Ren X, Maheras KJ, Emaus KJ, Gruley E, Chen Y, Neumar RW, Sanderson TH. Rapid Treatment with Intramuscular Magnesium Sulfate During Cardiopulmonary Resuscitation Does Not Provide Neuroprotection Following Cardiac Arrest. Mol Neurobiol. 2022 Mar;59(3):1872-1881. doi: 10.1007/s12035-021-02645-x. PMID: 35028899.
  4. Bryson TD, Harding P. Prostaglandin E2 EP receptors in cardiovascular disease: An update. Biochem Pharmacol. 2022 Jan;195:114858. doi: 10.1016/j.bcp.2021.114858. PMID: 34822808
  5. Gui H, She R, Luzum J, Li J, Bryson TD, Pinto Y, Sabbah HN, Williams LK, Lanfear DE. Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction. Circ Genom Precis Med. 2021 Jun;14(3):e003140. doi: 10.1161/CIRCGEN.120.003140. Epub 2021 May 17. PMID: 33999650
  6. Anzell AR, Fogo GM, Gurm Z, Raghunayakula S, Wider JM, Maheras KJ, Emaus KJ, Bryson TD, Wang M, Neumar RW, Przyklenk K, Sanderson TH. Mitochondrial fission and mitophagy are independent mechanisms regulating ischemia/reperfusion injury in primary neurons. Cell Death Dis. 2021 May 12;12(5):475. doi: 10.1038/s41419-021-03752-2. PMID: 33980811 Free PMC article.
  7. Fogo GM, Anzell AR, Maheras KJ, Raghunayakula S, Wider JM, Emaus KJ, Bryson TD, Bukowski MJ, Neumar RW, Przyklenk K, Sanderson TH. Machine learning-based classification of mitochondrial morphology in primary neurons and brain. Sci Rep. 2021 Mar 4;11(1):5133. doi: 10.1038/s41598-021-84528-8. PMID: 33664336
  8. Bryson TD, Pandrangi TS, Khan SZ, Xu J, Pavlov TS, Ortiz PA, Peterson E, Harding P. The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension. Am J Physiol Heart Circ Physiol. 2020 Apr 1;318(4):H867-H882. doi: 10.1152/ajpheart.00538.2019. PMID: 32142358
  9. Bryson TD, Ross J, Peterson E, Harding P. Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling. Prostaglandins Other Lipid Mediat. 2019 Jun 20;144:106349. doi: 10.1016/j.prostaglandins.2019.106349. PMID: 31229524
  10. Bryson T, Gu X, Khalil RM, Khan S, Zhu L, Xu J, Peterson E, Yang XP, Harding P. Overexpression of Prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2018 Mar 6;118:1-12. doi: 10.1016/j.yjmcc.2018.03.005 PMID: 29522761
  11. Gu X, Xu J, Zhu L, Bryson T, Yang XP, Peterson E, Harding P. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor. Circulation: Heart Failure Circ Heart Fail. 2016 Aug;9(8). pii: e003291. PMID: 27502370 PMCID: PMC4979610
  12. Fang J, Liu M, Zhang X, Sakamoto T, Taatjes DJ, Jena BP, Sun F, Woods J, Bryson T, Kowluru A, Zhang K, Chen X. COPII Dependent ER Export: a Critical Component of Insulin Biogenesis